Highlights of this program
Keynote addresses:
Anthony Fauci, National Institute of Allergy and Infectious Diseases
Solange Peters, Centre Hospitalier Universitaire Vaudois
Trevor Bedford, Fred Hutchinson Cancer Research Center
Additional speakers:
Norman E. Sharpless, Director, National Cancer Institute
Kizzmekia S. Corbett, National Institutes of Allergy and Infectious Diseases
Louis M. Staudt, National Cancer Institute
Kevan Shokat, University of California, San Francisco
Laura J. Esserman, UCSF Helen Diller Family Comprehensive Cancer Center
Cheryl L. Willman, University of New Mexico Comprehensive Cancer Center
John M. Carethers, University of Michigan
Symposia topics:
Intersection of the Biology of SARS-CoV-2 and Cancer
Effects of Cancer Immunotherapies on Patients with COVID-19 (with and without cancer)
COVID-19 Vaccine Development
Cancer Drug Repurposing to Treat COVID-19
Cancer Prevention and Early Detection During the COVID-19 Pandemic
Forum discussions:
Regulatory and Operational Implications of Cancer Clinical Trial Changes During COVID-19
Telehealth
How Will We bring Patients Back to the Clinic?
How Cancer Researchers Are Applying their Talents to COVID-19 Issues
Public-Private Partnerships Poised to Address COVID-19
Health Disparities